Risk Assessment on the Potential Public Health Impact of Vibrio Parahaemolyticus in Molluscan Shellfish; Request for Scientific Data and Information

Riepilogo

The Food and Drug Administration (FDA) is announcing a call for scientific data and information relevant to the agency's planned risk assessment on the potential public health impact of pathogenic Vibrio parahaemolyticus infections resulting from the consumption of raw molluscan shellfish. The risk assessment will assist FDA by providing a scientific framework for developing food safety policies relating to raw molluscan shellfish contaminated with pathogenic V. parahaemolyticus. FDA plans to hold public meetings to present the process of the risk assessment, to present information collected, and to allow interested parties additional opportunities to present data to facilitate this effort.